Epidemiology of Rhodotorula: An Emerging Pathogen

Table 2

Summary of reports of Rhodotorula infections other than fungemia from 2000 to 2011.

Reference	Species	Underlying disease	Infection site	Outcome
[70–73]	R. rubra; R. minuta	HIV; HCV; NU	Endophthalmitis; keratitis	Alive
[74–78]	R. rubra; R. glutinis; R. mucilaginosa	HIV; NU	Meningitis	Alive/Death
[79–81]	R. mucilaginosa; R. minuta	HIV; NU	Prosthetic joint	Alive
[82–86]	R. mucilaginosa	HIV, SOT; chronic renal failure	Peritonitis	Alive/Death
[87]	R. mucilaginosa	NU	Onychomycosis	Alive
[88, 89]	R. mucilaginosa	HIV,	Oral ulcers, dermatitis	Alive
[90]	R. mucilaginosa	NU	Arotic homograft endocarditis	Alive
[91]	R. mucilaginosa	HIV	Lymphadenitis	Alive

HCV: chronic hepatitis C; NU: no underlying disease described; SOT: solid organ transplant.